Literature DB >> 26708107

Prefrontal Reactivity to Social Signals of Threat as a Predictor of Treatment Response in Anxious Youth.

Autumn Kujawa1, James E Swain2, Gregory L Hanna2, Elizabeth Koschmann2, David Simpson1, Sucheta Connolly1, Kate D Fitzgerald2, Christopher S Monk2,3, K Luan Phan1,4,5,6.   

Abstract

Neuroimaging has shown promise as a tool to predict likelihood of treatment response in adult anxiety disorders, with potential implications for clinical decision-making. Despite the relatively high prevalence and emergence of anxiety disorders in youth, very little work has evaluated neural predictors of response to treatment. The goal of the current study was to examine brain function during emotional face processing as a predictor of response to treatment in children and adolescents (age 7-19 years; N=41) with generalized, social, and/or separation anxiety disorder. Prior to beginning treatment with the selective serotonin reuptake inhibitor (SSRI) sertraline or cognitive behavior therapy (CBT), participants completed an emotional faces matching task during functional magnetic resonance imaging (fMRI). Whole brain responses to threatening (ie, angry and fearful) and happy faces were examined as predictors of change in anxiety severity following treatment. Greater activation in inferior and superior frontal gyri, including dorsolateral prefrontal cortex and ventrolateral prefrontal cortex, as well as precentral/postcentral gyri during processing of threatening faces predicted greater response to CBT and SSRI treatment. For processing of happy faces, activation in postcentral gyrus was a significant predictor of treatment response. Post-hoc analyses indicated that effects were not significantly moderated by type of treatment. Findings suggest that greater activation in prefrontal regions involved in appraising and regulating responses to social signals of threat predict better response to SSRI and CBT treatment in anxious youth and that neuroimaging may be a useful tool for predicting how youth will respond to treatment.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 26708107      PMCID: PMC4908635          DOI: 10.1038/npp.2015.368

Source DB:  PubMed          Journal:  Neuropsychopharmacology        ISSN: 0893-133X            Impact factor:   7.853


  43 in total

1.  The amygdala response to emotional stimuli: a comparison of faces and scenes.

Authors:  Ahmad R Hariri; Alessandro Tessitore; Venkata S Mattay; Francesco Fera; Daniel R Weinberger
Journal:  Neuroimage       Date:  2002-09       Impact factor: 6.556

Review 2.  The developmental epidemiology of anxiety disorders: phenomenology, prevalence, and comorbidity.

Authors:  E Jane Costello; Helen L Egger; Adrian Angold
Journal:  Child Adolesc Psychiatr Clin N Am       Date:  2005-10

Review 3.  Neurobiology of emotion perception I: The neural basis of normal emotion perception.

Authors:  Mary L Phillips; Wayne C Drevets; Scott L Rauch; Richard Lane
Journal:  Biol Psychiatry       Date:  2003-09-01       Impact factor: 13.382

4.  Differential occurrence of comorbidity within childhood anxiety disorders.

Authors:  Timothy L Verduin; Philip C Kendall
Journal:  J Clin Child Adolesc Psychol       Date:  2003-06

5.  Social anxiety predicts amygdala activation in adolescents viewing fearful faces.

Authors:  William D S Killgore; Deborah A Yurgelun-Todd
Journal:  Neuroreport       Date:  2005-10-17       Impact factor: 1.837

6.  Life course outcomes of young people with anxiety disorders in adolescence.

Authors:  L J Woodward; D M Fergusson
Journal:  J Am Acad Child Adolesc Psychiatry       Date:  2001-09       Impact factor: 8.829

Review 7.  The cognitive control of emotion.

Authors:  Kevin N Ochsner; James J Gross
Journal:  Trends Cogn Sci       Date:  2005-05       Impact factor: 20.229

8.  Amygdala response to fearful faces in anxious and depressed children.

Authors:  K M Thomas; W C Drevets; R E Dahl; N D Ryan; B Birmaher; C H Eccard; D Axelson; P J Whalen; B J Casey
Journal:  Arch Gen Psychiatry       Date:  2001-11

9.  Ventrolateral prefrontal cortex activation and attentional bias in response to angry faces in adolescents with generalized anxiety disorder.

Authors:  Christopher S Monk; Eric E Nelson; Erin B McClure; Karin Mogg; Brendan P Bradley; Ellen Leibenluft; R James R Blair; Gang Chen; Dennis S Charney; Monique Ernst; Daniel S Pine
Journal:  Am J Psychiatry       Date:  2006-06       Impact factor: 18.112

10.  The Pediatric Anxiety Rating Scale (PARS): development and psychometric properties.

Authors: 
Journal:  J Am Acad Child Adolesc Psychiatry       Date:  2002-09       Impact factor: 8.829

View more
  22 in total

1.  Complementary Features of Attention Bias Modification Therapy and Cognitive-Behavioral Therapy in Pediatric Anxiety Disorders.

Authors:  Lauren K White; Stefanie Sequeira; Jennifer C Britton; Melissa A Brotman; Andrea L Gold; Erin Berman; Kenneth Towbin; Rany Abend; Nathan A Fox; Yair Bar-Haim; Ellen Leibenluft; Daniel S Pine
Journal:  Am J Psychiatry       Date:  2017-04-14       Impact factor: 18.112

2.  Reduced Reward Responsiveness Predicts Change in Depressive Symptoms in Anxious Children and Adolescents Following Treatment.

Authors:  Autumn Kujawa; Katie L Burkhouse; Shannon R Karich; Kate D Fitzgerald; Christopher S Monk; K Luan Phan
Journal:  J Child Adolesc Psychopharmacol       Date:  2019-05-07       Impact factor: 2.576

3.  Fear conditioning and extinction in anxious youth, offspring at-risk for anxiety and healthy comparisons: An fMRI study.

Authors:  Mélissa Chauret; Sabrina Suffren; Daniel S Pine; Marouane Nassim; Dave Saint-Amour; Françoise S Maheu
Journal:  Biol Psychol       Date:  2019-08-23       Impact factor: 3.251

Review 4.  Convergent neurobiological predictors of emergent psychopathology during adolescence.

Authors:  Scott A Jones; Angelica M Morales; Jessye B Lavine; Bonnie J Nagel
Journal:  Birth Defects Res       Date:  2017-12-01       Impact factor: 2.344

5.  Neural correlates of explicit and implicit emotion processing in relation to treatment response in pediatric anxiety.

Authors:  Katie L Burkhouse; Autumn Kujawa; Heide Klumpp; Kate D Fitzgerald; Christopher S Monk; K Luan Phan
Journal:  J Child Psychol Psychiatry       Date:  2016-11-08       Impact factor: 8.982

6.  Placebo Response in Pediatric Anxiety Disorders: Results from the Child/Adolescent Anxiety Multimodal Study.

Authors:  Jeffrey R Strawn; Eric T Dobson; Jeffrey A Mills; Gary J Cornwall; Dara Sakolsky; Boris Birmaher; Scott N Compton; John Piacentini; James T McCracken; Golda S Ginsburg; Phillip C Kendall; John T Walkup; Anne Marie Albano; Moira A Rynn
Journal:  J Child Adolesc Psychopharmacol       Date:  2017-04-06       Impact factor: 2.576

7.  Neural markers of attention to aversive pictures predict response to cognitive behavioral therapy in anxiety and depression.

Authors:  Jonathan P Stange; Annmarie MacNamara; Olga Barnas; Amy E Kennedy; Greg Hajcak; K Luan Phan; Heide Klumpp
Journal:  Biol Psychol       Date:  2016-10-23       Impact factor: 3.251

8.  Cortical Thickness and Subcortical Gray Matter Volume in Pediatric Anxiety Disorders.

Authors:  Andrea L Gold; Elizabeth R Steuber; Lauren K White; Jennifer Pacheco; Jessica F Sachs; David Pagliaccio; Erin Berman; Ellen Leibenluft; Daniel S Pine
Journal:  Neuropsychopharmacology       Date:  2017-04-24       Impact factor: 7.853

9.  Neural Reactivity to Angry Faces Predicts Treatment Response in Pediatric Anxiety.

Authors:  Nora Bunford; Autumn Kujawa; Kate D Fitzgerald; James E Swain; Gregory L Hanna; Elizabeth Koschmann; David Simpson; Sucheta Connolly; Christopher S Monk; K Luan Phan
Journal:  J Abnorm Child Psychol       Date:  2017-02

10.  Nucleus accumbens volume as a predictor of anxiety symptom improvement following CBT and SSRI treatment in two independent samples.

Authors:  Katie L Burkhouse; Nicholas Defelice; Heide Klumpp; Olusola Ajilore; Bobby Hosseini; Kate D Fitzgerald; Christopher S Monk; K Luan Phan
Journal:  Neuropsychopharmacology       Date:  2019-11-22       Impact factor: 7.853

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.